Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comments on Berry et al.'s response-adaptive randomization platform trial for Ebola

Erica H Brittain1, Michael A Proschan2

  • 1Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA ebrittain@niaid.nih.gov.

Clinical Trials (London, England)
|July 2, 2016
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.

Open forum infectious diseases·2026
Same author

Response-adaptive randomization with imperfect intermediate endpoints.

Clinical trials (London, England)·2026
Same author

Event-driven planning of two-armed trials with a binary endpoint.

Clinical trials (London, England)·2026
Same author

Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trial.

The journal of allergy and clinical immunology. Global·2025
Same author

Futility Monitoring in Clinical Trials.

Statistics in medicine·2025
Same author

Does Remdesivir Lower COVID-19 Mortality? A Subgroup Analysis of Hospitalized Adults Receiving Supplemental Oxygen.

Statistics in medicine·2024